Literature DB >> 27222202

Genome-wide analysis of the effect of esophageal squamous cell carcinoma on human umbilical vein endothelial cells.

Guoguo Jin1, Yi Yang1, Hangfan Liu1, Kangdong Liu1, Jimin Zhao1, Xinhuan Chen1, Xiaoyan Zhang1, Yanyan Zhang1, Jing Lu1, Ziming Dong1.   

Abstract

A large volume of data indicates that controlling tumor-associated angiogenesis is a promising therapy against cancer. However, angiogenesis is a complex process, little is known about the differential gene expression in the process of normal endothelial cell differentiation toward tumor vascular endothelial cells induced by tumor microenvironment. The aim of this study is to investigate the effect of tumor microenvironment simulated by the supernatant of esophageal squamous cancer cells (KYSE70) on normal endothelial cells (HUVECs) at the whole genome level. The gene expression profile was studied through gene ontology and signal pathway analysis. Compared with the normal HUVECs, a total of 3769 differentially expressed genes in induced HUVECs were detected, including 1609 upregulated genes and 2160 downregulated genes. Moreover, the microarray data analysis showed that 11 significant biological processes and 10 significant signaling pathways changed most, which are associated with angiogenesis and cell differentiation. According to the different expression levels in the microarrays and their functions, four differentially expressed genes involved in tumor angiogenesis and cell differentiation (IL6, VEGFA, S1PR1, TYMP) were selected and analyzed by qRT-PCR. The qRT-PCR results were consistent with the microarray data. Furthermore, we simulated the tumor microenvironment by human esophageal carcinoma tissue homogenate to investigate its effect on HUVECs, the qRT-PCR results indicated that the above genes were highly expressed in HUVECs after induction by esophageal carcinoma tissue homogenate. In conclusion, tumor microenvironment impact on normal endothelial cells differentiated toward tumor vascular endothelial cells, and the selected genes, which are associated with tumor angiogenesis, would be anti-angiogenesis targets against esophageal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27222202     DOI: 10.3892/or.2016.4816

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling.

Authors:  Ying Yue; Mengjia Song; Yamin Qiao; Pupu Li; Yiqiang Yuan; Jingyao Lian; Suying Wang; Yi Zhang
Journal:  Oncotarget       Date:  2017-10-30

2.  Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway.

Authors:  Yi Yang; Guoguo Jin; Hangfan Liu; Kangdong Liu; Jimin Zhao; Xinhuan Chen; Dongyu Wang; Ruihua Bai; Xiang Li; Yanan Jang; Jing Lu; Ying Xing; Ziming Dong
Journal:  Oncotarget       Date:  2017-08-18

3.  S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.

Authors:  Yan Liu; Yingru Zhi; Haizhu Song; Mingzhu Zong; Jun Yi; Guoxin Mao; Longbang Chen; Guichun Huang
Journal:  J Exp Clin Cancer Res       Date:  2019-08-22

4.  S1PR1 induces metabolic reprogramming of ceramide in vascular endothelial cells, affecting hepatocellular carcinoma angiogenesis and progression.

Authors:  Xuehong Wang; Zhidong Qiu; Wei Dong; Zebin Yang; Junnan Wang; Hailiang Xu; Tian Sun; Zhaoquan Huang; Junfei Jin
Journal:  Cell Death Dis       Date:  2022-09-06       Impact factor: 9.685

5.  Combination curcumin and (-)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway.

Authors:  G Jin; Y Yang; K Liu; J Zhao; X Chen; H Liu; R Bai; X Li; Y Jiang; X Zhang; J Lu; Z Dong
Journal:  Oncogenesis       Date:  2017-10-02       Impact factor: 7.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.